Gene Network Analysis of the Transcriptome Impact of SARS-CoV-2 Interacting MicroRNAs in COVID-19 DiseaseCOVID-19 질병에서 SARS-CoV-2 상호작용 MicroRNA의 전사체 영향에 대한 유전자 네트워크 분석Review Published on 2022-08-172022-09-11 Journal: International Journal of Molecular Sciences [Category] SARS, 유전자 메커니즘, [키워드] affected Analysis biochemical biological processes Cell cell cycle cell surface receptor changes characterized COVID-19 COVID-19 disease cytokine death DEGs differentially expressed differentially expressed gene Differentially expressed genes downregulated exploratory FIVE functional enrichment Functional enrichment analysis Gene Expression gene network Health Organization heart Impact involved kidneys list lung Lymph node microRNA MicroRNAs mitochondrial mitotic mitotic cell modulation molecular Multiorgan multiorgan disease network network analysis pathological mechanism Pathways Perspective predicted provide reported SARS-CoV-2 SARS-CoV-2 virus signaling pathway submitted surface receptor target tissue tissues transcriptomes translated upregulated WHO with COVID-19 World Health Organization [DOI] 10.3390/ijms23169239 PMC 바로가기 [Article Type] Review
SARS-CoV-2 antibody progression and neutralizing potential in mild symptomatic COVID-19 patients – a comparative long term post-infection studyArticle Published on 2022-08-172022-11-15 Journal: Frontiers in Immunology [Category] SARS, 진단, [키워드] acute infections addition Antibody titer block CLIA clinician Cohort comparability comparable convalescent COVID-19 disease COVID-19 patient Cutoff diagnostics ELISA FIVE help immune immune response increasingly individual immune response Infection information Laboratory long-COVID long-term assay comparison Mild mild progression COVID-19 mild SARS-CoV-2 infection Molecular diagnosis neutralization Neutralizing neutralizing potential Occurrence offered pandemic participant Participants Patient Post-infection progression quantification quantification immune response. Rapid SARS-CoV-2 SARS-CoV-2 antibody serological serological test specific antigen Support Symptom symptomatic vaccination Vaccine WHO [DOI] 10.3389/fimmu.2022.915338 PMC 바로가기
When Virtual Screening Yields Inactive Drugs: Dealing with False Theoretical FriendsArticle Published on 2022-08-172022-11-15 Journal: ChemMedChem [Category] COVID19(2023년), SARS, 신약개발, 치료제, [키워드] Antiviral antivirals biochemical biological assay Combination Compound computational method computational methods - biological assays conducted coronavirus COVID-19 drug design experimental group Friend initiated Intensive main protease molecular molnupiravir outbreak pandemic protease Remdesivir SARS-CoV-2 Screening severe cases Treatment Virtual screening WHO yield [DOI] 10.1002/cmdc.202200278 PMC 바로가기
Evaluation of Impact of a Pharmacist-Led Educational Campaign on Disease Knowledge, Practices and Medication Adherence for Type-2 Diabetic Patients: A Prospective Pre- and Post-AnalysisRandomized Controlled Trial Published on 2022-08-152022-10-05 Journal: International Journal of Environmental Research an [Category] 임상, [키워드] adherence Analysis analyzed Care conducted control group COVID-19 current diabete diabetes Diabetes Mellitus Diabetic diabetic patient disease effective evaluate First wave Follow-up glycemic control growth Impact Intervention intervention group knowledge knowledge score medication medication adherence Middle East multi-arm P -value Patient Pharmacist Practice practices pre-post analysis. problems Prospective public health randomly divided Saudi Arabia self-care significant difference significantly T2DM the disease Treatment Type usual care WHO World Health Organization [DOI] 10.3390/ijerph191610060 PMC 바로가기 [Article Type] Randomized Controlled Trial
The COVID-19 Pandemic: Reshaping Public Health Policy Response Envisioning Health as a Common GoodCOVID-19 팬데믹: 공동선으로서의 건강을 구상하는 공중 보건 정책 대응 재편Editorial Published on 2022-08-122022-09-11 Journal: International Journal of Environmental Research an [Category] SARS, 치료기술, [키워드] China Cluster common COVID-19 Good Health Organization Pneumonia Policy Public response unknown cause WHO World Health Organization Wuhan [DOI] 10.3390/ijerph19169985 PMC 바로가기 [Article Type] Editorial
How concerning is a SARS-CoV-2 variant of concern? Computational predictions and the variants labeling systemArticle Published on 2022-08-102022-11-16 Journal: Frontiers in Cellular and Infection Microbiology [Category] SARS, 변종, [키워드] Analysis approach attribute attributes CDC center computational prediction concerning Control COVID-19 pandemic criteria defined discrepancy Effect evaluated FIVE function Genetic variant Genetic variation labeling Mutation observation predict Predictive Premature prevention SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants the SARS-CoV-2 the United State These data variant variant of interest variant under monitoring variants variants of concern virus VoC VOCs WHO World Health Organization [DOI] 10.3389/fcimb.2022.868205 PMC 바로가기
2-deoxy-D-glucose as an adjunct to standard of care in the medical management of COVID-19: a proof-of-concept and dose-ranging randomised phase II clinical trialClinical Trial Published on 2022-08-042022-10-04 Journal: BMC Infectious Diseases [Category] SARS, 임상, [키워드] 2-deoxy-D-glucose 2-DG acute COVID-19 addition Administered adverse event age analyzed approach clinical benefit clinical recovery clinical study clinical trial conducted COVID-19 CTRI discharge dose efficacious therapeutic Efficacy Efficacy and safety evaluate evaluated hazard In-vitro intensive care Isolation limit management median metabolic inhibitor Mild moderate Mortality Negative conversion Normalisation Open-label outcomes Patient progression randomised randomised clinical trial Randomized receive reported RT-PCR SARS-CoV-2 severe COVID-19 severe COVID-19 patients shown significantly shorter standard care Standard of care time Tolerability treated Treatment Trial vital sign WHO [DOI] 10.1186/s12879-022-07642-6 PMC 바로가기 [Article Type] Clinical Trial
Allosteric Binding Sites of the SARS-CoV-2 Main Protease: Potential Targets for Broad-Spectrum Anti-Coronavirus AgentsSARS-CoV-2 주요 프로테아제의 알로스테릭 결합 부위: 광범위한 항 코로나바이러스 제제의 잠재적 표적Review Published on 2022-08-022022-09-11 Journal: Drug design, development and therapy [Category] SARS, 치료제, [키워드] affected agent allosteric sites Antiviral catalytic activity category caused Characteristics confirmed COVID-19 case COVID-19 COVID-19 disease deaths Disease progression drug target druggability enzyme evaluated explained feasibility Health Organization inhibitor life cycle M pro MPro Mutation pandemic Potential Potential treatment progression reached reported SARS-CoV-2 SARS-CoV-2 virus second Site subsequent target the disease the SARS-CoV-2 the SARS-CoV-2 virus WHO World Health Organization [DOI] 10.2147/DDDT.S370574 PMC 바로가기 [Article Type] Review
The burden of monkeypox virus amidst the Covid-19 pandemic in Africa: A double battle for AfricaShort communication Published on 2022-08-012022-10-05 Journal: Annals of Medicine and Surgery [Category] 치료기술, [키워드] Africa2 African caused clinical symptom contagious contributing to country COVID-19 COVID-19 cases Critical cross-protective immunity declining disease Disease surveillance Diseases effort fatigue Fever General population headache healthcare facility healthcare professionals Healthcare system impacted include inoculated International knowledge lack less Monkeypox Monkeypox virus MOST one health pandemic Rash risk Still Surveillance Symptom the disease Treatment vaccination Vaccine viral disease virus WHO zoonotic [DOI] 10.1016/j.amsu.2022.104197 [Article Type] Short communication
Predictive performance and clinical application of COV50, a urinary proteomic biomarker in early COVID-19 infection: a prospective multicentre cohort studyResearch article Published on 2022-08-012022-10-05 Journal: International Journal of Environmental Research an [Category] COVID19(2023년), SARS, 바이오마커, 유전자 메커니즘, 진단, [키워드] 95% CI Accuracy adjusted age Analysis AUC baseline Biomarker BMI capillary electrophoresis Care characteristic cohort study Comorbidities country COVID-19 dataset death died Disease progression eight Euro European country finding France funding Germany Greece high risk hospital hospitalisation Infection interim analysis less Logistic regression marker Markov chain Mild-to-moderate Ministry of Health Mortality multicentre North Odds ratio outcomes participant Participants PCR-confirmed PCR-confirmed COVID-19 peptide pilot study Poland predicted Predictive Probability progression proteomic recruited reducing reduction resulting risk SARS-CoV-2 SARS-CoV-2 pandemic Sex Spain threshold Treatment was used WHO [DOI] 10.1016/S2589-7500(22)00150-9 [Article Type] Research article